Capstone Asset Management’s AbbVie ABBV Stock Holding History

Capstone Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$15.6M	Sell	214,609 -3,373	-2%	-$227K	0.43%	45
2017 Q1	$14.2M	Buy	217,982 +5,209	+2%	+$327K	0.4%	49
2016 Q4	$13.3M	Buy	212,773 +2,089	+1%	+$128K	0.38%	54
2016 Q3	$13.3M	Buy	210,684 +5,485	+3%	+$355K	0.38%	52
2016 Q2	$12.7M	Buy	205,199 +59,231	+41%	+$3.61M	0.38%	48
2016 Q1	$8.34M	Sell	145,968 -1,787	-1%	-$99.6K	0.24%	103
2015 Q4	$8.75M	Sell	147,755 -175,124	-54%	-$10.1M	0.25%	94
2015 Q3	$17.6M	Buy	322,879 +14,237	+5%	+$927K	0.54%	23
2015 Q2	$20.7M	Buy	308,642 +143,674	+87%	+$9.38M	0.6%	14
2015 Q1	$9.66M	Sell	164,968 -2,074	-1%	-$125K	0.27%	87
2014 Q4	$10.9M	Buy	167,042 +25,366	+18%	+$1.6M	0.32%	70
2014 Q3	$8.18M	Sell	141,676 -13,324	-9%	-$740K	0.28%	82
2014 Q2	$8.75M	Sell	155,000 -24,387	-14%	-$1.28M	0.28%	73
2014 Q1	$9.22M	Sell	179,387 -20,520	-10%	-$1.04M	0.28%	75
2013 Q4	$10.6M	Sell	199,907 -95,575	-32%	-$4.7M	0.31%	59
2013 Q3	$13.2M	Sell	295,482 -6,954	-2%	-$308K	0.32%	51
2013 Q2	$12.5M	Buy	+302,436	New	+$13.2M	0.33%	50

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capstone Asset Management's ABBV Position: Q2 2017 in Review

Capstone Asset Management reduced its AbbVie (ABBV) stake by 1.5% in Q2 2017, selling an estimated $227K and leaving 214,609 shares worth $15.6M. The position accounts for 0.43% of the portfolio, ranked #45.

Capstone Asset Management first reported a position in ABBV in Q2 2013 and has held it in 17 quarters since. The position peaked at $20.7M in Q2 2015. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

Capstone Asset Management held 214,609 shares of AbbVie worth $15.6M as of Q2 2017.
Capstone Asset Management sold 3,373 AbbVie shares in Q2 2017, an estimated $227K.
AbbVie made up 0.43% of Capstone Asset Management's portfolio in Q2 2017, its #45 holding.
Capstone Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 17 quarters since.
Capstone Asset Management's AbbVie position peaked at $20.7M in Q2 2015.
1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.